Home › Targets › LAT1

LAT1 (1 companies · 6 programs)

Companies with an active program directed at LAT1.

Telix Pharmaceuticals Ltd TLX

  • TLX102-Tx — Leptomeningeal Disease Preclinical
  • iodofalan 131I — Glioblastoma Phase 3
  • TLX102-Tx — Glioblastoma Preclinical
  • TLX102-Tx — Multiple Myeloma Preclinical
  • Pixclara — Glioma Approved
  • Pixclara — Brain Metastases Phase 1